BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1600
+0.0019 (1.20%)
Nov 5, 2025, 4:00 PM EST
BioLargo Revenue
BioLargo had revenue of $2.78M in the quarter ending June 30, 2025, a decrease of -44.62%. This brings the company's revenue in the last twelve months to $14.05M, down -16.43% year-over-year. In the year 2024, BioLargo had annual revenue of $17.78M with 45.37% growth.
Revenue (ttm)
14.05M
Revenue Growth
-16.43%
P/S Ratio
3.54
Revenue / Employee
334.57K
Employees
44
Market Cap
49.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
| Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
| Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
| Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
| Dec 31, 2020 | 2.43M | 571.00K | 30.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cardinal Ethanol, LLC | 350.34M |
| The Monarch Cement Company | 252.15M |
| General Enterprise Ventures | 1.83M |
| Premier Development & Investment | 1.10M |
| Chykingyoung Investment Development Holdings | 305.65K |
| Panamera Holdings | 212.04K |
BioLargo News
- 2 days ago - BioLargo Cuts AEC PFAS Treatment Energy Use by >90%, Unlocking Commercial-Scale Water Solutions with Unmatched Total Life Cycle Cost Savings - Accesswire
- 15 days ago - BioLargo Presentation Deck at LD Micro Event Available Online - Accesswire
- 22 days ago - Biolargo Invites You to the Sustain SoCal 16th Annual Energy Event - A Premier Gathering for Clean Energy Innovation - Accesswire
- 22 days ago - BioLargo to Present Its Cellinity Battery Technology at LD Micro Main Event XIX in San Diego on Monday, October 20, at 2:00 p.m. PT - Accesswire
- 23 days ago - BioLargo Subsidiary Clyra Medical Accelerates Toward Near-Term Product Launches and Global Expansion - Accesswire
- 4 weeks ago - BioLargo Protects Its Intellectual Property That Built a National Brand - Pooph's License Was Revoked for Non-Payment and Unauthorized Activities - Accesswire
- 5 weeks ago - BioLargo Demonstrates Over 99% Removal of Ultrashort-Chain PFAS Including TFA Using Aqueous Electrostatic Concentration Technology - Accesswire
- 5 weeks ago - BioLargo to Showcase Breakthrough PFAS Solutions at WEFTEC 2025, Booth #6009 - Accesswire